NCT06017505
Integrating eSAGE With EHR Data Using Machine Learning for the Early Detection and Monitoring of Cognitive Impairment in Individuals
Enrolling by Invitation
Not specifiedAges 50+ObservationalDouglas ScharreInvestigator-initiated
~1,486 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:electronic self administered gerocognitive examination (eSAGE)
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Area Under the Curve (AUC) for the ROC analysis in predicting subjects with cognitive impairment from cognitively normal subjects.
Measured over 1 day visit
Conditions
Where it's being run
1 sites across 1 statesOhio1
Study leadership
- Douglas Scharre · PRINCIPAL_INVESTIGATOR · Ohio State University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
1\. Males and females 50 years of age and over who complete the eSAGE as part of their office visit at the Center for Cognitive and Memory Disorders.
Exclusion
None
What this trial measures
- Area Under the Curve (AUC) for the ROC analysis in predicting subjects with cognitive impairment from cognitively normal subjects.1 day visit
AUC ranges in value from 0 to 1